Abstract
Introduction
According to World Health Organization (WHO) statistics, nearly 250 million persons were affected by hearing impairment of some description in 2001, with auditory disorders being the most common congenital disease (1) (2) (3) (4) (5) . It has been demonstrated that the incidence rate of auditory disorders among high-risk newborns is up to 10 times higher than that in healthy neonates (6) . However, 78% of failure cases in primary screening tests are among well-baby nursery neonates (7) . The Joint Committee on Infants' Hearing (JCIH) has emphasized the importance of the early diagnosis and treatment of neonates with hearing impairments. The goal of early hearing detection and intervention (EHDI) is to preserve the maximum linguistic acquisition skills. JCIH strongly recommends that all neonates should be screened for auditory impairments up to 1 month of age, and if any problems are detected in primary tests, a comprehensive hearing assessment should be performed before 3 months of age. In those with confirmed hearing impairments, therapeutic intervention should be performed up to 6 months of age (8) . Researchers have demonstrated that the final outcome in infants who receive therapeutic intervention below 6 months of age is much higher than among those who are treated later, and that negligence in this regard may lead to verbal developmental delay (9) (10) (11) . Different studies have reported various risk factors for hearing loss (8, 12) . However, it has been noted that half of the patients with confirmed hearing impairment have no known JCIH risk factors. Therefore, screening limited to a high-risk population may lead to numerous patients being missed (13, 14) . Otoacoustic emission (OAE) and auditory steady state response (ASSR) tests are the most common tests in neonatal wards; with the ASSR test being utilized in case of false referral from the OAE test (15) (16) (17) . JCIH recommends that at least one auditory brainstem response (ABR) test be performed as a confirmatory audiology diagnostic evaluation in young children, while researchers have demonstrated that the ASSR test is a reasonable alternative to ABR and can be used to determine the pure tone threshold in neonates at risk for auditory disorders (8, (18) (19) . The aim of our study was to compare the prevalence of hearing loss in neonatal intensive care unit babies (high-risk group) with well-baby nursery babies (control group) using OAE and ASSR tests.
Materials and Methods
This The study showed that there were false positive cases in both the case and control groups, but the rate of false positives was higher in the case group than in the control group. The rate of false referrals from the OAE test has been estimated at approximately 7% ( 3%) (15) (16) (17) . In our study, the neonatal hearing impairment was approximately 3.5 neonates per 1,000 live births. According to universal statistics, this rate has been reported at approximately two to five neonates in 1,000 live births (6) . In a 2007 study by Korres et al., it was demonstrated that 78% of positive screening tests are from healthy babies with no risk factors (7). In our survey, 83% of positive screening tests were from well babies. Additionally, the JCIH 2007 guidelines state that half of all patients with confirmed hearing loss have no known risk factors for auditory disorders, emphasizing the value of universal screening programs rather than selective high-risk population screening (8) . It is known that the prevalence of hearing impairments in high-risk neonates could be up to 10-times higher than that in well babies (6) .
In a 2004 study conducted in Tehran University, 16% of neonates with NICU hospitalization had hearing loss. Although the authors demonstrated no significant relationship between NICU admission and hearing loss (20) , a study by Ur Rehman et al. in 2012 reported that 1.7% of NICU neonates had a hearing deficit compared with 0.2% of healthy newborns (21). In 2010, researchers in the Netherlands reported a 1.8% prevalence rate for hearing impairment among NICU neonates. They studied different risk indicators and their effect on variations in the prevalence of hearing loss in NICUs in the Netherlands, and found ethnicity to be a risk indicator (22) . In another study in the Netherlands, the prevalence of hearing loss among NICU newborns was cited as 3.2% (23) . In 1999, an evaluation of the efficacy of universal newborn hearing screening reported an estimated incidence of hearing deficit in NICU neonates of 2-4% (17). In our study, the prevalence of hearing disorders among NICU neonates was 1.9% (five out of 263), compared with 0.3% in RIU babies. This indicates a 6.5-times higher rate of hearing impairment in NICU neonates known as high-risk babies for auditory disorders.
Conclusion
In our study, the rate of hearing disorders among NICU neonates was 1.9%; 6.5-times that of RIU babies. In total, 84% of failure cases in screening tests were from RIU babies. This indicates that universal screening programs should be preferred over selective high-risk population screening.
